1. Drug Repurposing Patent Applications October–December 2018
   Hermann A.M. Mucke, 2019, ASSAY and Drug Development Technologies CrossRef
2. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System
   Chi Zhang et al, 2021, Journal of Cardiovascular Pharmacology CrossRef
3. Simvastatin as an emerging pollutant on non-target aquatic invertebrates: effects on antioxidant-related genes in Daphnia magna
   Sijia Liu et al, 2022, Environmental Science and Pollution Research CrossRef
4. Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline
   Tingting Jin et al, 2022, Molecular Medicine CrossRef
5. Increased Expression of Mevalonate Pathway-Related Enzymes in Angiotensin II-Induced Abdominal Aortic Aneurysms
   Yajun Liu et al, 2024, International Heart Journal CrossRef
6. Alendronate reduces periosteal microperfusion in vivo
   Danielle N. Kundert et al, 2023, Heliyon CrossRef
7. Ibandronate promotes autophagy by inhibiting Rac1–mTOR signaling pathway in vitro and in vivo
   Jie Han et al, 2022, Cell Death Discovery CrossRef
8. Extra-skeletal effects of bisphosphonates
   Argyro Panagiotakou et al, 2020, Metabolism CrossRef
9. Activation of autophagy during farnesyl pyrophosphate synthase inhibition is mediated through PI3K/AKT/mTOR signaling
   Jie Han et al, 2020, Journal of International Medical Research CrossRef
10. Inhibition of the mevalonate pathway improves myocardial fibrosis
    Huifeng Xu et al, 2021, Experimental and Therapeutic Medicine CrossRef